These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21524586)

  • 1. Inhibitory potential of chemical substitutions at bioinspired sites of β-D-galactopyranose on neoglycoprotein/cell surface binding of two classes of medically relevant lectins.
    Giguère D; André S; Bonin MA; Bellefleur MA; Provencal A; Cloutier P; Pucci B; Roy R; Gabius HJ
    Bioorg Med Chem; 2011 May; 19(10):3280-7. PubMed ID: 21524586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calix[n]arene-based glycoclusters: bioactivity of thiourea-linked galactose/lactose moieties as inhibitors of binding of medically relevant lectins to a glycoprotein and cell-surface glycoconjugates and selectivity among human adhesion/growth-regulatory galectins.
    André S; Sansone F; Kaltner H; Casnati A; Kopitz J; Gabius HJ; Ungaro R
    Chembiochem; 2008 Jul; 9(10):1649-61. PubMed ID: 18509838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persubstituted cyclodextrin-based glycoclusters as inhibitors of protein-carbohydrate recognition using purified plant and mammalian lectins and wild-type and lectin-gene-transfected tumor cells as targets.
    André S; Kaltner H; Furuike T; Nishimura S; Gabius HJ
    Bioconjug Chem; 2004; 15(1):87-98. PubMed ID: 14733587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of bivalent lactosides based on terephthalamide, N,N'-diglucosylterephthalamide, and glycophane scaffolds and assessment of their inhibitory capacity on medically relevant lectins.
    Leyden R; Velasco-Torrijos T; André S; Gouin S; Gabius HJ; Murphy PV
    J Org Chem; 2009 Dec; 74(23):9010-26. PubMed ID: 19899775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symmetric dithiodigalactoside: strategic combination of binding studies and detection of selectivity between a plant toxin and human lectins.
    Martín-Santamaría S; André S; Buzamet E; Caraballo R; Fernández-Cureses G; Morando M; Ribeiro JP; Ramírez-Gualito K; de Pascual-Teresa B; Cañada FJ; Menéndez M; Ramström O; Jiménez-Barbero J; Solís D; Gabius HJ
    Org Biomol Chem; 2011 Aug; 9(15):5445-55. PubMed ID: 21660340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic neoglycodecapeptides: how to increase their inhibitory activity and selectivity on lectin/toxin binding to a glycoprotein and cells.
    André S; Renaudet O; Bossu I; Dumy P; Gabius HJ
    J Pept Sci; 2011 Jun; 17(6):427-37. PubMed ID: 21294229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lectin-based drug design: combined strategy to identify lead compounds using STD NMR spectroscopy, solid-phase assays and cell binding for a plant toxin model.
    Ribeiro JP; André S; Cañada FJ; Gabius HJ; Butera AP; Alves RJ; Jiménez-Barbero J
    ChemMedChem; 2010 Mar; 5(3):415-9, 314. PubMed ID: 20094999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbamate-linked lactose: design of clusters and evidence for selectivity to block binding of human lectins to (neo)glycoproteins with increasing degree of branching and to tumor cells.
    André S; Specker D; Bovin NV; Lensch M; Kaltner H; Gabius HJ; Wittmann V
    Bioconjug Chem; 2009 Sep; 20(9):1716-28. PubMed ID: 19715307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosyldisulfides from dynamic combinatorial libraries as O-glycoside mimetics for plant and endogenous lectins: their reactivities in solid-phase and cell assays and conformational analysis by molecular dynamics simulations.
    André S; Pei Z; Siebert HC; Ramström O; Gabius HJ
    Bioorg Med Chem; 2006 Sep; 14(18):6314-26. PubMed ID: 16782346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction profile of galectin-5 with free saccharides and mammalian glycoproteins: probing its fine specificity and the effect of naturally clustered ligand presentation.
    Wu AM; Singh T; Wu JH; Lensch M; André S; Gabius HJ
    Glycobiology; 2006 Jun; 16(6):524-37. PubMed ID: 16540530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First demonstration of differential inhibition of lectin binding by synthetic tri- and tetravalent glycoclusters from cross-coupling of rigidified 2-propynyl lactoside.
    André S; Liu B; Gabius HJ; Roy R
    Org Biomol Chem; 2003 Nov; 1(22):3909-16. PubMed ID: 14664382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.
    Rapoport EM; André S; Kurmyshkina OV; Pochechueva TV; Severov VV; Pazynina GV; Gabius HJ; Bovin NV
    Glycobiology; 2008 Apr; 18(4):315-24. PubMed ID: 18256179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AB-type lectin (toxin/agglutinin) from mistletoe: differences in affinity of the two galactoside-binding Trp/Tyr-sites and regulation of their functionality by monomer/dimer equilibrium.
    Jiménez M; André S; Siebert HC; Gabius HJ; Solís D
    Glycobiology; 2006 Oct; 16(10):926-37. PubMed ID: 16774910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further refinement of the description of the ligand-binding characteristics for the galactoside-binding mistletoe lectin, a plant agglutinin with immunomodulatory potency.
    Galanina OE; Kaltner H; Khraltsova LS; Bovin NV; Gabius HJ
    J Mol Recognit; 1997; 10(3):139-47. PubMed ID: 9408830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycocluster design for improved avidity and selectivity in blocking human lectin/plant toxin binding to glycoproteins and cells.
    André S; Lahmann M; Gabius HJ; Oscarson S
    Mol Pharm; 2010 Dec; 7(6):2270-9. PubMed ID: 21028902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bi- to tetravalent glycoclusters presenting GlcNAc/GalNAc as inhibitors: from plant agglutinins to human macrophage galactose-type lectin (CD301) and galectins.
    André S; O'Sullivan S; Koller C; Murphy PV; Gabius HJ
    Org Biomol Chem; 2015 Apr; 13(14):4190-203. PubMed ID: 25721929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the potential of aglycone modifications for affinity/selectivity enhancement against medically relevant lectins: synthesis, activity screening, and HSQC-based NMR analysis.
    Rauthu SR; Shiao TC; André S; Miller MC; Madej É; Mayo KH; Gabius HJ; Roy R
    Chembiochem; 2015 Jan; 16(1):126-39. PubMed ID: 25407851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bi- to tetravalent glycoclusters: synthesis, structure-activity profiles as lectin inhibitors and impact of combining both valency and headgroup tailoring on selectivity.
    Wang GN; André S; Gabius HJ; Murphy PV
    Org Biomol Chem; 2012 Sep; 10(34):6893-907. PubMed ID: 22842468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bivalent O-glycoside mimetics with S/disulfide/Se substitutions and aromatic core: Synthesis, molecular modeling and inhibitory activity on biomedically relevant lectins in assays of increasing physiological relevance.
    Kaltner H; Szabó T; Fehér K; André S; Balla S; Manning JC; Szilágyi L; Gabius HJ
    Bioorg Med Chem; 2017 Jun; 25(12):3158-3170. PubMed ID: 28483453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoglycoproteins with the synthetic complex biantennary nonasaccharide or its alpha 2,3/alpha 2,6-sialylated derivatives: their preparation, assessment of their ligand properties for purified lectins, for tumor cells in vitro, and in tissue sections, and their biodistribution in tumor-bearing mice.
    André S; Unverzagt C; Kojima S; Dong X; Fink C; Kayser K; Gabius HJ
    Bioconjug Chem; 1997; 8(6):845-55. PubMed ID: 9404657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.